Related Experiment Video
Updated: Oct 31, 2025

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
Published on: June 5, 2021
Long-Term Persistence of Anti-SARS-CoV-2 Antibodies in a Pediatric Population
Ana Méndez-Echevarría1, Talía Sainz1, Iker Falces-Romero2
1Pediatrics and Infectious Disease Unit, La Paz University Hospital, Translational Research Network of Pediatric Infectious Diseases (RITIP), 28049 Madrid, Spain.
Insights
Most children infected with SARS-CoV-2 maintain positive IgG antibodies six months post-infection. Antibody loss was more common in asymptomatic or mildly symptomatic children with initially low antibody titers.
Area of Science:
- Pediatric Infectious Diseases
- Immunology
- Virology
Background:
- Antibody dynamics following SARS-CoV-2 infection in children remain poorly understood.
- Limited data exists on long-term antibody responses in pediatric populations.
Purpose of the Study:
- To investigate the persistence of SARS-CoV-2 specific IgG antibodies in children up to six months post-infection.
- To identify factors associated with antibody loss in pediatric COVID-19 cases.
Main Methods:
- A prospective cohort study involving 58 children infected with SARS-CoV-2 between March and May 2020.
- Children were categorized into hospitalized COVID-19, mild outpatient COVID-19, and asymptomatic seropositive contacts.
- Serological testing for IgG antibodies was performed at baseline and six months post-infection.
Main Results:
- 86% of children maintained positive IgG antibodies six months after infection.
- Higher initial IgG titers and diagnoses of lower respiratory tract infection or multisystemic inflammatory syndrome were associated with sustained antibody response.
- Children of healthcare workers in the seroprevalence study lost antibodies more frequently.
Conclusions:
- The majority of children infected with SARS-CoV-2 exhibit sustained IgG antibody responses six months post-infection.
- Antibody loss is more likely in children with asymptomatic or mild infections and lower initial antibody titers.
Background:
Antibody dynamics over time after SARS-CoV-2 infection are still unclear, and data regarding children are scarce.
Methods:
A prospective cohort study was performed including children infected by SARS-CoV-2 between March and May 2020. Patients were categorized into 3 groups: children admitted with COVID-19; outpatient children with mild COVID-19; and seropositive children participating in a seroprevalence study among cohabitants of infected healthcare workers (HCWs). Six months after the infection, a new serological control was performed.
Results:
A total of 58 children were included, 50% male (median age 8.3 [IQR 2.8-13.5] years). The median time between the two serological studies was 186 (IQR 176-192) days, and 86% (48/56) of the children maintained positive IgG six months after the infection. This percentage was 100% in admitted patients and 78% among the rest of the included children (p = 0.022). The diagnoses of lower respiratory tract infection and multisystemic inflammatory syndrome were associated with persistence of IgG (p = 0.035). The children of HCWs in the seroprevalence study lost antibodies more often (p = 0.017). Initial IgG titers of the children who remained positive six months after the infection were significantly higher (p = 0.008).
Conclusions:
Most children infected by SARS-CoV-2 maintain a positive serological response six months after the infection. Those children who lost their IgG titer were more frequently asymptomatic or mildly symptomatic, presenting with low antibody titers after the infection.
Related Concept Videos
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Active versus Passive Immunity
Active Immunity
Active immunity refers to the resistance one develops...

